Nektar Therapeutics (NKTR) Tops Q4 EPS by 19c
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $73.02 -3.82%
Financial Fact:
General and administrative: 10.25M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
General and administrative: 10.25M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q4 EPS of $0.03, $0.19 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $29.2 million versus the consensus estimate of $29.81 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
